A multicentre trial for the treatment of dermatophyte onychomycosis of
the toenails with terbinafine was carried out in Australia and New Ze
aland. Between eight and 12 nail samples were obtained from each of th
e 118 patients in the 48-week trial, and each sample was investigated
by direct microscopy and culture for dermatophyte and non-dermatophyte
fungi, Patients were randomized to treatment with terbinafine at 250
mg/day or placebo for the first 12 weeks of the study, then nonrespond
ers were offered a 12-week course of terbinafine from week 28. All pat
ients had a dermatophyte infection. In 42 patients (36%) microscopy an
d mycological culture identified dermatophytes alone. In the remaining
76 patients (64%), a non-dermatophyte mould or yeast was also isolate
d at some stage during the trial, but in only three patients did the s
ame non-dermatophyte persist in two or more successive nail specimens.
The presence of a fungal contaminant in addition to a dermatophyte ha
d no apparent effect on the efficacy of treatment with terbinafine. Mi
e conclude that non-dermatophyte moulds and yeasts are generally found
as contaminating organisms in dermatophyte onychomycosis, secondary t
o the dermatophytes, and that they do not influence the outcome of tre
atment.